January 27th 2016, MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V – “RLV”) (Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce the formation of its new corporate advisory board comprised of individuals with a wealth of experience in sports therapy, functional movement and consumer goods marketing in order to assist with the selection, negotiation and integration of potential business acquisitions.
Relevium’s corporate strategy is focused on acquiring businesses and/or technologies all within the scope of the rapidly expanding health and wellness sector within three main verticals: Pain Relief, Injury Recovery and Performance. Management is currently engaged in the review of multiple potential targets.
Relevium is pleased to announce the following additions to its advisory board:
Aurelio Useche MBA. CPA. CMA. ICD.D
Providing guidance and support over the M&A activities of the company, Mr. Useche leverages over 20 years of senior management experience in private and publicly traded corporations including manufacturing, mining exploration and consumer products. Aurelio serves on the board of several private and public companies and holds an executive MBA from Queens School of Business he holds a CPA-CMA accreditation and is also a graduate of the Directors Program from the Rotman School of Business.
Enrique Fidalgo, BSPC
Providing guidance and support over the sports performance segment of the business, Enrique Fidalgo is a trained Functional Movement Specialist formally trained at the University of Miami and Professional Sports Coach (BSpC), Swimming Coach, CSCS, TSAC-F. In addition to his training and athletics coaching career, Enrique worked for various non-for-profit organizations helping build national and international community centers in the goal of providing opportunities for underprivileged individuals to attain academic formations and participate in sports.
Jay A. Kiss, N.D
Providing guidance and support over the pain management and injury recovery segment of the business, Jay A. Kiss is the founder of SPC Physio in 1996 and as a Sports Therapist, Jay has successfully treated, trained and rehabilitated numerous world class, Olympic and professional athletes. Jay co-developed and put in place a unique system called F.I.T.T.S, the Flexible Integrated Therapy and Training System. The F.I.T.T.S philosophy encompasses several cutting edge manual therapy, evaluation and training techniques which has become his clinic’s winning formula.
Mackendy Begin LLB
Mackendy is co-founder of Virtual & Business Group Executive Strategy Consultant and a Managing Partner at REDBARLO Productions. An experienced consultant in the fields of News Media, Funding, Consumer goods marketing and Entertainment Management. Mackendy has a law degree from University of Ottawa.
Leena Lakdawala, CEO of Relevium Technologies Inc. stated: “Relevium’s corporate strategy leverages a growing demand in the Health and Wellness sector. Our company intends to deliver a combined product offering that combines technologies that address each of the three market segments identified in our corporate strategy”. Relevium’s advisory board will work closely with management in the evaluation of new opportunities in addition to providing management with expertise in the fields of Pain, Recovery and Performance”.
About Relevium Technologies Inc.
Relevium is focused on growth through the acquisition of businesses, products and/or technologies all within the scope of the expanding health and wellness sector under three unique verticals: Pain Relief, Recovery and Performance.
Relevium Technologies Inc. currently holds patented intellectual property for application on direct-to-consumer devices which aid in decreasing pain, improving recovery time and enhancing performance. The company is developing and will commercialize several products for various related applications including a line of sleep and wellness products; all designed to enhance physical well-being.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
CEO and Director
For additional information, please contact:
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the business and operations of the Company. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the ability of the Company to execute and achieve its business objectives. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.